Abstracts in 2010
2 abstracts have been accepted for ASCO, Chicago, June 2010
1. Quinten C, Martinelli F, Vercauteren J, Greimel E, Reeve B.B., Taphoorn MJ, Cleeland C.S, Weis J, Schmucker-Von Koch J, Bottomley A, on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. Use of health-related quality of life and clinical data as prognostic tools for survival prediction in a subgroup of metastatic cancer patients. 46th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago (USA), June 2010. J Clin Oncol 28:7s, 2010 (suppl; abstr 9146)
2. Vercauteren J, Maringwa J, Coens C, Quinten C, Gotay C, Ringash J, King M, Osoba D, Flechtner H, Bottomley, A. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. The association between clinical, sociodemographic, and logistic-administrative factors and adherence to completing health-related quality-of-life questionnaires. 46th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago (USA), June 2010. J Clin Oncol 28:7s, 2010 (suppl; abstr 9075)
3 Abstracts have been accepted for UICC, Shenzen, August 2010
1. Bottomley A, Carolyn G, Osoba D, Ringash J, Schmucker-Von Koch J. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. Making best use of existing clinical trials data- a global project on QOL: PROBE on behalf of the EORTC, the NCIC-CTG, MRC, the AGO.
2. Quinten C, Reeve B, King M, Flechtner H, Weis J. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. Incorporating health related quality of life alongside clinical data may improve the survival prognosis of cancer patients; an update of a provisional analysis of pooled EORTC studies.
3. Martinelli F, Maringwa J, Cleeland , Greimel E, Taphoorn M, on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. Dynamic structure of HRQoL indicators: what has been done and what will be done in the PROBE project.
3 Abstracts have been accepted for ISOQOL, London, October 2010
1. Quinten C, Martinelli F, Coens C, Maringwa J, Cleeland C, Flechtner H, Gotay C,
Greimel E, King M, Osoba D, Taphoorn MJB, Reeve B, Ringash J, Schmucker-
Von Koch J, Weis J, Bottomley A. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. Investigating heterogeneity for survival in a pooled cancer cohort of more than 10,000 patients from 30 EORTC Randomized Trials.
2 .Maringwa J, Coens C, Quinten C, Martinelli F, Ringash J, Osoba D, Reeve B, King M, Cleeland C, Flechtner H, Gotay C, Greimel E, Taphoorn MJ, Schumucker-von Koch J, Weis J, Smit EF, van Meerbeeck JP, Bottomley A. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. Investigating heterogeneity for survival in a pooled cancer cohort of more than 10,000 patients from 30 EORTC Randomized Trials.
3. Martinelli F, Quinten C, Maringwa J,Coens C, Cleeland C, Gotay C, Reeve B, Ringash J, Flechtner H, Greimel E, Osoba D, King M, Schmucker-Von Koch J, Taphoorn M, Weis J, Fosså S , Albrecht W, Van Poppel H, Powell P, Johnson M, Bottomley A. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. Clustering of Health-related Quality of Life (HRQOL) items in Metastatic Prostate Cancer Patients.
3 Abstracts (1 Issue panel discussion and 2 posters) have been accepted for ISPOR, Prague, November 2010
1. Quinten C, Flechtner H, Bottomley A. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. Are genetics directly linked with cancer patient reported Quality of Life outcomes? A debate based on scientific evidence.
2. Bottomley A, Quinten C, Mauer M, Taphoorn MJ, Flechtner H, Koller M, Ghislain I, Coens C. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. A Database Review of Patient Reported Outcome studies in EORTC Cancer Clinical Trials.
3. Maringwa J, Quinten C, King M, Ringash J, Osoba D, Coens C, Martinelli F, Reeve BB, Gotay C, Greimel E, Flechtner H,Cleeland C, Schmucker-Von Koch J, Weis J, Van Den Bent MJ, Stupp R, Taphoorn MJ, Bottomley A. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. Minimal Clinically Meaningful Differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 Scales in Brain Cancer Patients.
